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Letter to the Editor
Reply to Oliver W Quarrell et al.:
“Letter in response to Tibben et al.,
Risk Assessment for Huntington’s
Disease for (Future) Offspring Requires
Offering Preconceptional CAG Analysis
to Both Partners”
Aad Tibbena,∗, Wybo J. Dondorpb, Guido M. de Wertb, Christine E. de Die-Smuldersc,
Moniek Losekoota and Emilia K. Bijlsmaa
aDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
bDepartment of Health, Ethics and Society, Maastricht University, Maastricht, The Netherlands
cDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands
Dear Editor,
We are grateful to Quarell and others for their
response [1] to our article [2], and for the opportunity
to respond. The authors feel that the case for altering
the current guidelines for predictive testing for Hunt-
ington’s disease [3] has not yet been made because
of insufficient information about the behaviour of
intermediate alleles (IA), reduced penetrance alleles
(RPA), and fully penetrant alleles (FPA) in families
not yet identified as Huntington families. We agree
with the authors that more knowledge of and insight
into the dynamics of the alleles is needed to justify
changing the guidelines. However, we want to meet
the concerns of couples who wish to have offspring
but feel the responsibility for preventing the concep-
tion or birth of a child with an HD allele. One of the
main reasons of individuals at risk to request predic-
∗Correspondence to: Aad Tibben, PhD, Leiden University
Medical Center, Department of Clinical Genetics, P.O Box 9600,
2300 RC Leiden, The Netherlands. Tel.: +31 71 526 8033; Fax:
+31 71 526 6794; E-mail: a.tibben@lumc.nl.
tive testing is the wish to have children. Until now,
tested individuals expect that either test result allows
them to exclude HD in their offspring, in case of a
unfavourable test result by opting for prenatal (PND)
or preimplantation genetic testing (PGT). The aim of
genetic counseling, in general [4] and according to the
guidelines [3], is to give individuals at risk, who wish
to take the predictive test, up to date, relevant informa-
tion in order to make an informed voluntary decision.
Moreover, couples opting for prenatal testing should
be made fully aware of all possible outcomes and
consequences of prenatal testing [3].
The question of an identified non-carrier, whether
the chance of Huntington in his or her offspring is
excluded, cannot be confirmed because of the - albeit
very small - chance of an expanded repeat in the non-
HD partner. Similarly, a carrier and his or her partner,
opting for PND or PGT, need to be informed that
prenatal testing might reveal a small chance that an
expanded repeat will be found in the non-HD partner.
Consequently, couples deserve to be well informed
and counseled so that they can make a decision that
does justice to their reproductive concerns.
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The authors compare our case with chromosome
microarray analyses in the context of PND that might
elicit some copy number variants that may predis-
pose to developmental disability or neuropsychiatric
illness. Moreover, their comparison with expanded
carrier screening for cystic fibrosis, spinal muscular
atrophy or fragile X concerns decisions in the context
of population screening, which makes this analogy
invalid.
Quarell c.s. seem to assume that we propose to rou-
tinely test the non-HD partners - which they would
not prefer. We definitely agree on the latter as rou-
tine testing is not our point. We argue that this test
should be an option in counseling couples in this
specific situation. We acknowledge the concerns and
uncertainties surrounding this additional testing, but
that is no reason not to discuss this testing opportu-
nity with couples who might want to use it because
of their specific request for help, c.q. prevention of
Huntington’s disease in offspring. Whether counsel-
ing is offered from a non-directive counseling model
or a shared decision-making model, in our opinion
couples need to be fully informed. But given the
uncertainties and complexities of the alleles in ques-
tion, we do think that discussing and possibly offering
an additional test for non-HD partners should take
place in a research setting to investigate what sound
counseling entails in this context.
Aad Tibben, PhD
Wybo J. Dondorp, PhD
Guido M. de Wert, PhD
Christine E. de Die-Smulders, MD, PhD
Moniek Losekoot, PhD
Emilia K. Bijlsma MD, PhD
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